Position in ZTS
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$2,120,660
+$1,721,500 QoQ
Shares Held
29,511
+981.8% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#474
of 1,412 holders
Holding Since
Sep 2021
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FOX RUN MANAGEMENT, L.L.C. holds $6,581,949 across 12 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (32.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
29,511 | $2,120,660 | |
| 2 | INDV |
Indivior Pharmaceuticals, Inc.
|
24,876 | $1,020,662 | |
| 3 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
44,817 | $804,913 | |
| 4 | BHC |
Bausch Health Companies Inc.
|
139,728 | $688,859 | |
| 5 | ELAN |
Elanco Animal Health Inc
|
18,952 | $466,408 | |
| 6 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
14,556 | $293,740 | |
| 7 | TLRY |
Tilray Brands, Inc.
|
63,112 | $283,372 | |
| 8 | AMRX |
Amneal Pharmaceuticals, Inc.
|
16,028 | $277,444 |
All Filings in ZTS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,120,660 | 29,511 | Shares | Sole | 2026-08-04 | |
| 2025-09-30 | $399,160 | 2,728 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,882,004 | 12,068 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $1,580,969 | 9,602 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,490,483 | 9,148 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $291,897 | 1,494 | Shares | Sole | 2024-11-12 | |
| 2023-06-30 | $207,340 | 1,204 | Shares | Sole | 2023-08-11 | |
| 2021-12-31 | $267,944 | 1,098 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $427,302 | 2,201 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||